SBIR Phase I: Low-Cost Isotope Battery for Long-Lived Applications

SBIR 第一阶段：适用于长寿命应用的低成本同位素电池

• 批准号: 2304501
• 负责人: Kirsten Adams
• 金额: $ 27.48万
• 依托单位: NU PLANET PHARMACEUTICAL RADIOISOTOPES, INC.
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-10-01 至 2024-09-30
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=2304501&HistoricalAwards=false
• 关键词: SBIR; Phase; Low; Cost; Isotope

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project includes creating radioisotope materials which can be used for high performance power production decay batteries used in deep space, medical applications, unmanned drones, and other uses. These materials will be able to provide electrical power for months or years at a time enabling game changing technologies by enabling ubiquitous and readily available nuclear power to become a reality. Not only can this technology be used for power, but the specific isotopes produced can also support efforts to fight cancer, perform medical imaging, and explore natural resources. According to Allied Market Research, nuclear driven battery markets are expected to reach $87.2 billion by 2026.The unique capabilities of radioisotopes can provide many benefits in many different areas, but their rarity often limits their use. This SBIR Phase I project seeks to generate a power-producing radioisotope material from a naturally-occurring source and show that it can be used for power in a long-lived nuclear battery. The technical hurdles for this project include being able to use radioisotopes not currently considered for decay batteries and generating useful amounts of radioisotopes for an attractive cost. In order to overcome these hurdles, a functioning prototype will be constructed and driven with isotopes made at NPPR to empirically show feasibility. This will be accomplished by demonstrating the ability to induce radioactive decay in the feedstock, collecting the radioisotope produced, and showing its use in a power source. With the developments made in this project, radioisotopes will be more readily available. Medical, aerospace, defense, and many other markets will see great opportunities for advancement with the newly available materials.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.

这项小型企业创新研究（SBIR）I期项目的更广泛的影响/商业潜力包括创建可放射性同位素材料，可用于高性能生产衰减电池，用于深空，医疗应用，无人驾驶无人机和其他用途。这些材料将能够在几个月或几年的时间内提供电力，从而通过使无处不在且随时可用的核电成为现实，从而实现改变游戏的技术。该技术不仅可以用于电力，而且生产的特定同位素也可以支持与癌症，进行医学成像和探索自然资源的努力。根据盟军市场研究，到2026年，核驱动的电池市场预计将达到872亿美元。放射性病的独特功能可以在许多不同的领域提供许多好处，但它们的稀有性通常会限制其使用。这个SBIR I期项目旨在从自然出现的来源中生成产生功率的放射性同位素材料，并表明它可用于长寿命的核电池中的功率。 该项目的技术障碍包括能够使用当前未考虑用于衰减电池的放射性同位素，并产生有用的放射性同位素以获得有吸引力的成本。为了克服这些障碍，将使用在NPPR上制造的同位素来构建和驱动功能的原型，以凭经验显示可行性。这将通过证明在原料中诱导放射性衰减的能力来实现，收集产生的放射性同位素并显示其在电源中的使用。随着该项目的发展，放射性同位素将更容易获得。医疗，航空航天，国防和许多其他市场将通过新的材料看到巨大的进步机会。该奖项反映了NSF的法定任务，并被认为是值得通过基金会的知识分子优点和更广泛影响的评估标准来通过评估来获得支持的。